Kawatou, Masahide
Masumoto, Hidetoshi
Fukushima, Hiroyuki
Morinaga, Gaku
Sakata, Ryuzo
Ashihara, Takashi
Yamashita, Jun K.
Article History
Received: 19 November 2016
Accepted: 21 August 2017
First Online: 20 October 2017
Competing interests
: J. K. Yamashita is a founder, equity holder, and scientific adviser of iHeart Japan Corporation. J. K. Yamashita and H. Masumoto are co-inventors on multiple pluripotent stem cell-related patents. This study was funded by research grants from the Japan Agency for Medical Research and Development, iHeart Japan Corporation, Nippon Boehringer Ingelheim Co., Ltd. and Takara Bio Inc. The remaining authors declare no competing financial interests.